Thursday, December 8, 2022



Contact us 561.316.3330

4 Ways Clinical MDMA Therapy Is Paving Way For PTSD Treatment

MDMA Therapy

Post-Traumatic Stress Disorder (PTSD) is a mental health disorder that occurs after an individual experiences or sees a terrifying event. If not treated promptly, the patient may develop anxiety, depression, severe drug and alcohol abuse, and, in some cases, suicidal ideation. Mental health practitioners and researchers have been trying to treat PTSD for years with different therapy techniques and medications. Patients with PTSD have been prescribed medications that are not specifically designed to treat the condition. The said medications were typically for mood and anxiety disorders but are now used for PTSD patients as well.

Many patients with PTSD struggle to complete psychotherapy because it’s difficult for them to be emotionally involved enough to participate in them. Moreover, research has shown that more than half of the people who receive psychotherapy until the end of their sessions still have PTSD symptoms after. This could be due to their failure to actively participate in therapy and fully confront the traumatic event so that they can face their reality. As a result, trauma remains in the subconscious, and symptoms such as nightmares may persist.

So, to aid in the treatment of PTSD, studies have been conducted to determine which medications work best when combined with therapy to increase patient participation in the process. MDMA (methylenedioxymethamphetamine) is one drug that has been subjected to clinical trials to determine its efficacy in treating PTSD in conjunction with psychotherapy techniques, and their results have been promising. So if you’re a psychiatrist or clinical psychologist you could try to find a MDMA supplier to obtain the medicine for your therapy sessions with PTSD patients.

MDMA is best known as the street drug molly or ecstasy. Some people illegally use the drug to help increase their energy and mood. Because of its effects, MDMA has been used to treat PTSD patients by helping them become more willing to participate in therapy. MDMA therapy is the name given to the combination of MDMA and therapy.

If you want to know more about MDMA, you could visit other sites exclusively for sanctioned medical MDMA use like to learn more. Meanwhile, this article will discuss how MDMA therapy is paving the way for PTSD treatment. 

  • It Helps Patients Maintain Their Composure Throughout Therapy.

The discovery of clinical MDMA therapy could be the beginning of better treatment for PTSD as it allows patients to be calm for the most crucial parts of psychotherapy. MDMA research has revealed that the drug interacts with neuroreceptor sites in the brain and central nervous system. Such interaction promotes the production of serotonin, a chemical messenger that aids in the regulation of mood and memory and allows patients to remain calm during therapy sessions.

Because of this, patients can calmly face and express their traumatic incident or other difficult episodes while in session. It means that using MDMA therapy may result in fewer patients absconding from treatment, as one of the reasons they did so was due to too much pressure, tension, and failure to deal with difficult episodes.

  • It Reduces The Amount Of Time It Takes For PSTD Patients To Heal

PSTD recovery can take anywhere from six months to a year or more, depending on the patient. However, when a patient is given MDMA medication before the therapy session, it enables a multi-approach to PTSD treatment. The drug’s properties, such as boosting mood and energy, allow and assist the patient in confronting the tragic event causing the stress disorder.

As a result, the number of sessions that a patient used to receive before the development of MDMA therapy is reduced. Rather than establishing the stressor, more time can be spent attempting to overcome the feelings caused by the trauma. It means that MDMA therapy is helping to accelerate the treatment of PTSD because the drug encourages the patient to take an active role for the therapy to continue.

  • It Fosters Good Rapport Between Patient And Therapist

MDMA therapy is a PTSD treatment method that fosters a positive relationship between the patient and the therapist. Most PTSD patients may have difficulty trusting others with their feelings or sharing their innermost thoughts about the tragedy they experienced. It could be because some of these patients tend to blame themselves for the mishap, and being open to anyone would be a threat to their personality. As a result, researchers working on the treatment of PTSD needed to find a way to suppress the patients’ mistrust, and they discovered that MDMA can help patients bond with their therapists.

The MDMA medication, when given to the patient before therapy, also increases oxytocin levels. Oxytocin is a hormone that is also called the ‘love hormone’ due to its qualities of enabling social bonding and intimacy. Therefore, once the patient receives the medication, they are encouraged to bond with the therapist, be more open with them, and develop trust, which is a stepping stone that allows for successful therapy. So, MDMA therapy certainly is a way PTSD can be treated in an environment of trust.

  • Helps Patients With PTSD Overcome Difficult Mental Situations

Lastly, the most helpful thing that clinical MDMA therapy can give to patients with PTSD is overcoming mental dilemmas. The MDMA medication also increases dopamine levels in the body. Dopamine contributes to feelings of euphoria and the ability to plan and solve difficulties. Therefore, when used in patients with PTSD, it allows them to be able to process their painful thoughts. Once they manage to process the grueling episodes, it becomes easier for them to overcome the mental situations.


So far, clinical MDMA therapy has proven to be a modified method of treating PTSD. The administration of MDMA medication to a PTSD patient before psychotherapy has shown to benefit the patient’s resilience. This is because MDMA medication promotes the production of numerous chemicals that relaxes the patient, allow them to be more open with the therapist, and assist them in confronting and overcoming grueling mental issues. It is a breakthrough that neither therapy nor MDMR can achieve alone. However, the combination of the two, known as MDMA therapy, is a significant step forward in the treatment of PTSD.


Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.
- Subscribe -spot_img
- Our Sister Publication - Biotechnology News Magazine -spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy